呼吁标准化报告患者报告结局指标:临床相关性比率
本文探讨了骨科手术中患者报告结局指标(PROMs)的标准化报告问题,指出仅报告均值变化可能高估治疗效果并遗漏未达到临床阈值的患者。作者提出应使用最小临床重要差异(MCID)和患者可接受症状状态(PASS)等临床阈值,并引入「临床相关性比率」这一新指标,该比率不受随访丢失患者的影响。
要点
- 均值变化报告PROMs可能高估整体治疗效果,遗漏未达临床阈值的患者。
- 临床重要性应通过MCID和PASS等阈值报告,而非仅均值变化。
- 临床相关性比率将结局二分化,报告达到临床重要的患者数占总纳入患者数的比例。
核心结论
- 建议采用包含MCID和PASS的标准化PROMs报告方式,并引入临床相关性比率。
- 临床相关性比率不易受随访丢失患者的影响,优于其他常见报告方法。
研究设计与样本
- 本文为论坛讨论,使用模拟数据集以全关节置换术为例建模PROMs。
主要发现
- 常用均值变化报告PROMs可能高估队列整体治疗效果,并遗漏低于临床相关阈值的不同患者群体。
- 临床相关性比率定义为在特定时间点达到临床重要的患者数除以研究纳入的总患者数。
关键数值与推荐
- MCID定义为患者感知为有益的最小治疗结局变化。
- PASS定义为患者认为自身状况良好的最高症状水平。
临床怎么用
- 在骨科手术研究中报告PROMs时,应同时报告MCID和PASS达标情况。
- 可采用临床相关性比率作为标准化报告指标,以更准确反映临床重要性。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A shift toward a value-driven health-care model has made prospective collection of patient-reported outcome measures (PROMs) inextricably tied to measuring the success of orthopaedic surgery and patient satisfaction. While progress has been made in optimizing the utilization of PROM data, including establishing appropriate PROMs for a procedure and determining the clinical importance of unique tools, if these PROMs are not accurately analyzed and reported, a proportion of patients who do not reach the clinical thresholds may go unnoticed. Furthermore, parameters are unclear for setting a statistically and clinically important PROM threshold along with a minimum period for follow-up data collection.In this forum, we walk through simulated data sets modeling PROMs with the example of total joint arthroplasty. We discuss how the commonly used method of reporting PROMs by mean change can overestimate the treatment effects for the cohort as a whole and fail to capture distinct populations that are below a clinically relevant threshold. We demonstrate that when a study's outcome is PROMs, clinical importance should be reported using clinical thresholds such as the minimum clinically important difference (MCID), the smallest change in the treatment outcome that a patient perceives as beneficial, and the patient acceptable symptom state (PASS), the highest level of symptoms beyond which a patient considers himself or herself well. Finally, we propose a standardized reporting of PROMs that incorporates both the MCID and the PASS, and introduce a "clinical relevance ratio," which relies on a clinically relevant threshold to dichotomize outcomes and reports the number of patients achieving clinical importance at a given time point divided by the total number of patients included in the study. Unlike other common PROM-reporting approaches, the clinical relevance ratio is not skewed by patients who are lost to follow-up with increased time.
引用
- Orr MN, Klika AK, Gagnier JJ, et al. A Call for a Standardized Approach to Reporting Patient-Reported Outcome Measures: Clinical Relevance Ratio. J Bone Joint Surg Am. 2021. PMID: 34101690. doi:10.2106/JBJS.21.00030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。